Shrudemi Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.50 M
as on 17-12-2024
- Company Age 15 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.99 M
as on 17-12-2024
- Satisfied Charges ₹ 5.00 M
as on 17-12-2024
About Shrudemi Pharma
The Corporate was formerly known as Shree Varahi Flour & Foods Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.99 M. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shrutiben Patel and Devangkumar Patel serve as directors at the Company.
- CIN/LLPIN
U24100GJ2010PTC059188
- Company No.
059188
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Shrudemi Pharma Private Limited offer?
Shrudemi Pharma Private Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Pain Reliever Gel, Diclofenac Diethylamine Gel, Antifungal Injection, Tablet & Syrup, Itraconazole Capsule and Tablet, Antifungal Cream, Ointment & Powder, Luliconazole Cream.
Who are the key members and board of directors at Shrudemi Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrutiben Patel  | Director | 08-Dec-2016 | Current |
| Devangkumar Patel | Director | 08-Dec-2016 | Current |
Financial Performance of Shrudemi Pharma.
Shrudemi Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shrudemi Pharma?
In 2017, Shrudemi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 11 Oct 2021 | ₹0.99 M | Open |
The Mehsana Urban Cooperative Bank Limited Creation Date: 24 Dec 2010 | ₹2.50 M | Satisfied |
The Mehsana Urban Cooperative Bank Limited Creation Date: 20 Dec 2010 | ₹2.50 M | Satisfied |
How Many Employees Work at Shrudemi Pharma?
Unlock and access historical data on people associated with Shrudemi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrudemi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrudemi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
